下載本文檔
版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemEIsosilybinCat. No.: HY-N0779CAS No.: 72581-71-6Synonyms: Isosilybinin分式: CHO分量: 482.44作靶點(diǎn): Cytochrome P450作通路: Metabolic Enzyme/Protease儲(chǔ)存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 month溶解性數(shù)據(jù)體外實(shí)驗(yàn) DMSO : 28 mg
2、/mL (58.04 mM)* means soluble, but saturation unknown.Mass Solvent1 mg 5 mg 10 mg Concentration制備儲(chǔ)備液1 mM 2.0728 mL 10.3640 mL 20.7280 mL5 mM 0.4146 mL 2.0728 mL 4.1456 mL10 mM 0.2073 mL 1.0364 mL 2.0728 mL請(qǐng)根據(jù)產(chǎn)品在不同溶劑中的溶解度,選擇合適的溶劑配制儲(chǔ)備液,并請(qǐng)注意儲(chǔ)備液的保存式和期限。BIOLOGICAL ACTIVITY物活性 Isosilybin (Isosilybinin)來(lái)乳薊
3、的類黃酮;抑制CYP3A4誘導(dǎo)的IC50值為74 M。IC50 & Target IC50: 74 M (CYP3A4) 1體外研究The reporter gene assay shows that milk thistles components silybin and isosilybin are responsible for the1/2 Master of Small Molecules 您邊的抑制劑師www.MedChemEinhibition of PXR-mediated CYP3A4 induction by milk thistle. Compared with sily
4、bin, its isomer isosilybin is astronger inhibitor of PXR-mediated CYP3A4 induction. A solution of 89, 133, and 200 M isosilybinsignificantly inhibits CYP3A4 induction by 64, 82, and 88%, respectively. Isosilybin inhibits CYP3A4 inductionwith an IC50 of 74 M 1. Isosilybin B and isosilybin A, two dias
5、tereoisomers isolated from silymarin, haveanti-prostate cancer (PCA) activity that is mediated via cell cycle arrest and apoptosis induction. Isosilybin Band isosilybin A treatment results in growth inhibition and cell death together with a strong G(1) arrest andapoptosis in human prostate cancer LN
6、CaP and 22Rv1 cells 2. Isosilybin B causes increasedphosphorylation of Akt (Ser-473 and Thr-308) and Mdm2 (Ser-166), which is linked with androgen receptordegradation as pretreatment with PI3K inhibitor (LY294002)-restored androgen receptor level. Isosilybin Btreatment enhances the formation of comp
7、lex between Akt, Mdm2 and AR, which promotes phosphorylation-dependent AR ubiquitination and its degradation by proteasome 3. Isosilybin A is able to significantlyactivate PPAR at a concentration of 30 M (2.080.48 fold, p 4.PROTOCOLCell Assay 2 LNCaP cells and 22Rv1 cells are plated and treated at 4
8、050% confluency with different doses of isosilybinB and isosilybin A (1090 M in medium) dissolved originally in Dimethyl sulfoxide (DMSO) for the desiredtime periods (2448 h) in serum condition. An equal amount of DMSO (vehicle) is present in each treatment,including control; DMSO concentration did
9、not exceed 0.1% (v/v) in any treatment. At the end of desiredtreatments, total cell number is determined by counting each sample in duplicate using a hemocytometerunder an inverted microscope. Cell viability is determined using trypan blue exclusion method 2.MCE has not independently confirmed the a
10、ccuracy of these methods. They are for reference only.REFERENCES1. Mooiman KD, et al. Milk thistles active components silybin and isosilybin: novel inhibitors of PXR-mediated CYP3A4 induction. DrugMetab Dispos. 2013 Aug;41(8):1494-504.2. Deep G, et al. Isosilybin B and isosilybin A inhibit growth, i
11、nduce G1 arrest and cause apoptosis in human prostate cancer LNCaP and22Rv1 cells. Carcinogenesis. 2007 Jul;28(7):1533-42.3. Deep G, et al. Isosilybin B causes androgen receptor degradation in human prostate carcinoma cells via PI3K-Akt-Mdm2-mediatedpathway. Oncogene. 2008 Jun 26;27(28):3986-98.4. Pferschy-Wenzig EM, et al. Identification of isosilybin a from milk thistle seeds as an agonist of peroxisome proliferator-activatedreceptor gamma. J Nat Prod. 2014 Apr 25;77(4):842-7.McePdfHeightCaution: Product
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 二零二五年度舉升機(jī)租賃與節(jié)能改造服務(wù)合同3篇
- 2024版工程設(shè)計(jì)協(xié)作協(xié)議樣式一
- 2023-2028年中國(guó)多囊卵巢綜合征藥物行業(yè)發(fā)展監(jiān)測(cè)及行業(yè)市場(chǎng)深度研究報(bào)告
- 2025年度安防監(jiān)控設(shè)備租賃與維保合同2篇
- 2024漁業(yè)船舶油料清倉(cāng)及油罐拆卸合同
- 2024版出租車包車合同
- 2025年互聯(lián)網(wǎng)醫(yī)療平臺(tái)服務(wù)合作協(xié)議
- 二零二五年度反擔(dān)保保證合同:跨境電商業(yè)務(wù)3篇
- 二零二五年度二手車買賣及殘值回購(gòu)協(xié)議3篇
- 2024年電氣設(shè)備生產(chǎn)與銷售合同
- 工會(huì)經(jīng)費(fèi)收支預(yù)算表
- 舒爾特方格55格200張?zhí)岣邔W⒘4紙直接打印版
- 質(zhì)量管理體系各條款的審核重點(diǎn)
- 聚丙烯化學(xué)品安全技術(shù)說(shuō)明書(MSDS)
- 流動(dòng)資金測(cè)算公式
- BBC美麗中國(guó)英文字幕
- 衛(wèi)生院工程施工組織設(shè)計(jì)方案
- CDR-臨床癡呆評(píng)定量表
- 《八年級(jí)下學(xué)期語(yǔ)文教學(xué)個(gè)人工作總結(jié)》
- 鋁合金門窗制作工藝卡片 - 修改
- 恒亞水泥廠電工基礎(chǔ)試題
評(píng)論
0/150
提交評(píng)論